LivaNova PLC - Ordinary Shares (LIVN) News

LivaNova PLC - Ordinary Shares (LIVN)

Today's Latest Price: $54.25 USD

0.68 (1.27%)

Updated Nov 27 1:00pm

Add LIVN to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 143 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

Filter LIVN News Items

LIVN News Results

Event/Time Symbol Company News Detail Start End Change POWR Rating
Loading, please wait...

Latest LIVN News From Around the Web

Below are the latest news stories about LivaNova PLC that investors may wish to consider to help them evaluate LIVN as an investment opportunity.

Artificial Cardiopulmonary Machine Market 2020-28 plays a crucial role of the heart and lungs during surgical procedures| LivaNova, Terumo CV Group, Getinge, Medtronic, Tianjin Medical, Braile Biomedica

Artificial heart-lung machine, commonly known as Artificial Cardiopulmonary Machine or cardiopulmonary bypass pump, is used to take the role of the heart and lungs during any cardiovascular surgical procedure. The Artificial Cardiopulmonary Machine Market report is an extensive, proficient and

OpenPR | September 28, 2020

LivaNova to Host Conference Call for Third Quarter 2020 Results

LONDON--(BUSINESS WIRE)---- $LIVN--LivaNova PLC will host a conference call to discuss its third quarter 2020 results on Thursday, October 29, 2020 at 12 p.m. London (8 a.m. EDT).

Business Wire | September 28, 2020

LivaNova to Present at the Baird 2020 Global Healthcare Conference

LONDON--(BUSINESS WIRE)---- $LIVN--LivaNova PLC announced Damien McDonald, CEO, will present at the Baird 2020 Global Healthcare Conference on Thursday, Sept. 10 at 9:05 a.m. EDT.

Business Wire | September 1, 2020

LivaNova to Present Autonomic Regulation Therapy Findings for Heart Failure During European Society of Cardiology Congress 2020

LONDON--(BUSINESS WIRE)---- $LIVN--LivaNova poster at ESC 2020 to share potential for autonomic regulation therapy to improve heart failure patients' long-term cardiovascular function.

Business Wire | August 12, 2020

Global Neurology Devices Market (2019 to 2025) - Featuring LivaNova, Magstim & Medtronic Among Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Neurology Devices Market 2019-2025" report has been added to ResearchAndMarkets.com's offering. The global neurology devices market is estimated to witness significant growth during the forecast period. Increasing demand for neurostimulation devices is one of the factors that are driving the market growth. Rising prevalence of neurological disorders, including Parkinson's and Alzheimer's disease has led the adoption of neurostimulation devices. In addition, rising

Business Wire | August 10, 2020

LivaNova PLC (LIVN) CEO Damien McDonald on Q2 2020 Results - Earnings Call Transcript

LivaNova PLC (LIVN) Q2 2020 Earnings Conference Call July 29, 2020 07:00 AM ET Company Participants Matthew Dodds - Senior Vice President of Corporate Development Damien McDonald - Chief Executive Officer Thad Huston - Chief Financial Officer Melissa Farina - Vice President of Investor Relations Conference Call Participants Matthew O'Brien...

SA Transcripts on Seeking Alpha | August 2, 2020

LivaNova Reports Second Quarter 2020 Results

LONDON--(BUSINESS WIRE)---- $LIVN--LivaNova PLC, a market-leading medical technology and innovation company, today reported results for the quarter ended June 30, 2020.

Business Wire | July 29, 2020

Analysts Estimate LivaNova (LIVN) to Report a Decline in Earnings: What to Look Out for

LivaNova (LIVN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | July 22, 2020

Did Hedge Funds Make The Right Call On LivaNova PLC (LIVN) ?

The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F filings show the funds' and investors' portfolio positions as of March 31st, a week after the market trough. Now, we are […]

Yahoo | July 20, 2020

LivaNova Announces Commercial Launch of Perceval Plus Aortic Heart Valve in Europe

LONDON--(BUSINESS WIRE)---- $LIVN--LivaNova PLC today announced the advanced Perceval® Plus sutureless surgical aortic heart valve is now available for commercial release in Europe.

Business Wire | July 16, 2020



Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7108 seconds.